A Successful Bridge Therapy Combining Hypomethylating Agents with Venetoclax for Adult Patients with Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia.

导出 OA

翻译打印收藏纠错

第一作者： Su-Yeon,Bang

第一单位： Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.

作者： Su-Yeon,Bang ^[1] ; Silvia,Park ^[2] ; Daehun,Kwag ^[1] ; Jong Hyuk,Lee ^[2] ; Gi-June,Min ^[1] ; Sung-Soo,Park ^[2] ; Jae-Ho,Yoon ^[1] ; Sung-Eun,Lee ^[2] ; Byung-Sik,Cho ^[1] ; Ki-Seong,Eom ^[2] ; Yoo-Jin,Kim ^[1] ; Seok,Lee ^[2] ; Chang-Ki,Min ^[1] ; Seok-Goo,Cho ^[2] ; Jong Wook,Lee ^[1] ; Hee-Je,Kim ^[2]

作者单位： Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea. ^[1] Leukemia Research Institute, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea. ^[2]

关键词 acute myeloid leukemia allogeneic transplantation hypomethylating agents venetoclax

DOI 10.3390/cancers15061666

PMID 36980551

发布时间 2023-03-31

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交